228 related articles for article (PubMed ID: 29610390)
1. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.
Beird HC; Wu CC; Ingram DR; Wang WL; Alimohamed A; Gumbs C; Little L; Song X; Feig BW; Roland CL; Zhang J; Benjamin RS; Hwu P; Lazar AJ; Futreal PA; Somaiah N
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610390
[TBL] [Abstract][Full Text] [Related]
2. CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomen.
Lee S; Park H; Ha SY; Paik KY; Lee SE; Kim JM; Park JB; Kwon CH; Joh JW; Choi YL; Kim SJ
PLoS One; 2014; 9(8):e99452. PubMed ID: 25121597
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
[TBL] [Abstract][Full Text] [Related]
5. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review.
Assi T; Kattan J; Rassy E; Nassereddine H; Farhat F; Honore C; Le Cesne A; Adam J; Mir O
Crit Rev Oncol Hematol; 2020 Sep; 153():103029. PubMed ID: 32593094
[TBL] [Abstract][Full Text] [Related]
6. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.
Gronchi A; Collini P; Miceli R; Valeri B; Renne SL; Dagrada G; Fiore M; Sanfilippo R; Barisella M; Colombo C; Morosi C; Stacchiotti S; Casali PG; Dei Tos AP; Pilotti S
Am J Surg Pathol; 2015 Mar; 39(3):383-93. PubMed ID: 25581729
[TBL] [Abstract][Full Text] [Related]
7. A single institutional experience treating adipocytic tumors: incidence, disease-related outcomes, and the clinical significance of MDM2 analysis.
Tamkus S; Gusho CA; Colman MW; Miller I; Gitelis S; Blank AT
Orthop Rev (Pavia); 2020 Nov; 12(3):8818. PubMed ID: 33312490
[TBL] [Abstract][Full Text] [Related]
8. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma.
Tseng WW; Chopra S; Engleman EG; Pollock RE
Front Oncol; 2016; 6():134. PubMed ID: 27376027
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness.
Yoo Y; Park SY; Jo EB; Choi M; Lee KW; Hong D; Lee S; Lee CR; Lee Y; Um JY; Park JB; Seo SW; Choi YL; Kim S; Lee SG; Choi M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206586
[TBL] [Abstract][Full Text] [Related]
11. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches.
Lahat G; Anaya DA; Wang X; Tuvin D; Lev D; Pollock RE
Ann Surg Oncol; 2008 Jun; 15(6):1585-93. PubMed ID: 18398663
[TBL] [Abstract][Full Text] [Related]
12. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP
Mod Pathol; 2024 Apr; 37(6):100494. PubMed ID: 38621503
[TBL] [Abstract][Full Text] [Related]
13. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
[TBL] [Abstract][Full Text] [Related]
14. Integrated exome and RNA sequencing of dedifferentiated liposarcoma.
Hirata M; Asano N; Katayama K; Yoshida A; Tsuda Y; Sekimizu M; Mitani S; Kobayashi E; Komiyama M; Fujimoto H; Goto T; Iwamoto Y; Naka N; Iwata S; Nishida Y; Hiruma T; Hiraga H; Kawano H; Motoi T; Oda Y; Matsubara D; Fujita M; Shibata T; Nakagawa H; Nakayama R; Kondo T; Imoto S; Miyano S; Kawai A; Yamaguchi R; Ichikawa H; Matsuda K
Nat Commun; 2019 Dec; 10(1):5683. PubMed ID: 31831742
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
16. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas.
Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A
J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K
Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
[TBL] [Abstract][Full Text] [Related]
19. Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma.
Amin-Mansour A; George S; Sioletic S; Carter SL; Rosenberg M; Taylor-Weiner A; Stewart C; Chevalier A; Seepo S; Tracy A; Getz G; Hornick JL; Nucci MR; Quade B; Demetri GD; Raut CP; Garraway LA; Van Allen EM; Wagner AJ
Clin Cancer Res; 2019 Aug; 25(16):5135-5142. PubMed ID: 31164371
[TBL] [Abstract][Full Text] [Related]
20. Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma.
Shimoji T; Kanda H; Kitagawa T; Kadota K; Asai R; Takahashi K; Kawaguchi N; Matsumoto S; Hayashizaki Y; Okazaki Y; Shinomiya K
Biochem Biophys Res Commun; 2004 Feb; 314(4):1133-40. PubMed ID: 14751251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]